Strumento inattivo

Azioni Optimer Pharmaceuticals, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	04/10/13
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	29/08/13
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	12/08/13
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	01/08/13
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	01/08/13

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,24%	86,85 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,16 Mrd
BIOGEN INC.	-16,52%	31,28 Mrd
UCB	+57,86%	25,27 Mrd
BIOMARIN PHARMACEUTICAL INC.	-14,07%	15,33 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	11,96 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,61 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+6,89%	8,83 Mrd
INNOVENT BIOLOGICS, INC.	-10,53%	7,94 Mrd